BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Engineering Events - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Engineering Events
X-ORIGINAL-URL:https://seasevents.nmsdev7.com
X-WR-CALDESC:Events for Penn Engineering Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240214T153000
DTEND;TZID=America/New_York:20240214T163000
DTSTAMP:20260403T191338
CREATED:20240116T180348Z
LAST-MODIFIED:20240116T180348Z
UID:10463-1707924600-1707928200@seasevents.nmsdev7.com
SUMMARY:CBE Seminar: "Systems Engineering for Addressing Critical Challenges in Viral Vector Manufacturing" (Francesco Destro\, MIT)
DESCRIPTION:Abstract\nThe demand for viral vectors is poised to soon exceed current production capacities\, driven by the surging number of clinical trials for gene and cell therapies. Unfortunately\, current manufacturing processes for viral vectors have high costs and low titers. This talk will demonstrate how process systems engineering tools can be leveraged for addressing the most critical challenges in the manufacturing process for recombinant adeno-associated virus (rAAV)\, the most widely used viral vector in commercial gene therapies. FDA recently approved the first rAAV-based gene therapies manufactured in the Sf9/baculovirus expression vector system (BEVS). Within the BEVS\, Sf9 cells produce rAAV as a result of infection with recombinant baculoviruses that carry the genetic blueprint for vector production. A mechanistic model is developed to identify the bottlenecks to full capsid formation in the intracellular pathway for rAAV production in Sf9 cells. The model indicates genetic modifications to the baculovirus vectors that can enhance the productivity of the platform. Further\, the optimal process conditions to establish continuous rAAV manufacturing in the BEVS are identified through a novel numerical method for solving systems of partial differential equations. Finally\, a powerful machine learning model is introduced for real-time prediction of rAAV titers based on single-cell biophysical signatures.
URL:https://seasevents.nmsdev7.com/event/cbe-seminar-systems-engineering-for-addressing-critical-challenges-in-viral-vector-manufacturing-francesco-destro-mit/
LOCATION:Wu and Chen Auditorium (Room 101)\, Levine Hall\, 3330 Walnut Street\, Philadelphia\, PA\, 19104\, United States
CATEGORIES:Seminar
ORGANIZER;CN="Chemical and Biomolecular Engineering":MAILTO:cbemail@seas.upenn.edu
END:VEVENT
END:VCALENDAR